GM The responsibility for the failed developement of AOD falls largely at the feet of the original board.
At the time the company put out a paper hypothesising that oral availability was to blame for not achieving statistical significance. There has been rodent studies confirmimg oral availability. JV has previously made a strong case the clinical trials were bungled. GRAS is the money option after a failed trial with no takers for funding further developement. Have a look at the unscientifically tested rubbish on the chemists shelves. It may be academia is very wary of supporting a failed drug , even a GRAS, which should be beyond doubt after all the trial subjects. The BB industry is doing a lot of valuable clinical trials! They even have an improved diet regime with dose first in morning then fast and a second dose in the evening.
I have read oral needs four times the dosage of injectable. As JV has stated a legal , mass produced cost of goods should blow the pirates out of the water. I feel your pain GM at the time i lost a house deposit. Biotech is high risk, remember the caveat forward looking statements etc At least biotech is altruistic , saving lives etc. Its not like cannabals with forks like the carbon lobby poisoning the earth for future generations.
CZD Price at posting:
4.6¢ Sentiment: Hold Disclosure: Held